授乳中の腎臓保存薬の使用について
Paula Parnizari1, Jonathan Zipursky2, Michelle A Hladunewich3
1Unidad Academica de Nefrología, Hospital de Clinicas "Manuel Quintela", Facultad de Medicina, Universidad de la República, Montevideo, Uruguay.
Kidney international
|February 15, 2026
まとめ
授乳は,慢性腎臓病 (CKD) を患っている母親とその乳児にとって,健康上の大きな利点をもたらします. しかし,授乳中の薬剤の安全性に関する限られたデータは,必須のCKD治療へのアクセスを阻害する可能性があります.
科学分野:
- ネフロロジーは腎臓科
- 哺乳期 薬理学
- 妊産婦・胎児医学について
背景:
- 母乳育児は,高血圧や糖尿病のリスクを軽減するなど,母と乳児の血管健康に多大な利点をもたらします.
- 慢性腎臓病 (CKD) の女性は,特定の産後治療を必要としますが,多くのCKD薬の授乳安全性データは不足しています.
- この赤字は,CKDの母親が最適な治療を受け,母乳の保護効果から恩恵を受けるのを妨げることがあります.
研究 の 目的:
- 慢性腎臓病の母親とその乳児に対する母乳の重要性を検討する.
- CKD治療に使用される薬剤の授乳時の安全性に関する既存のデータを要約する.
- 哺乳期における薬剤の安全性を評価するための方法を探求し,薬剤測定モデリングを含む.
主な方法:
- CKDにおける母乳育児の利点に関する文献レビュー.
- 授乳中のCKD薬の安全性に関する現在のデータの分析.
- 薬物安全性評価方法論と薬量測定モデリングの議論.
主要な成果:
- 授乳は母親の血管健康に良い影響を与え,肥満,高血圧,糖尿病の乳児のリスクを軽減します.
- 哺乳期における多くのCKD薬の安全性に関する知識に重大なギャップがあります.
- 薬剤測定モデリングは,限られたヒトデータで,授乳中の薬剤の安全性を評価するための有望なアプローチを提供します.
結論:
- 哺乳は,CKDの母親とその子供にとって極めて重要であり,健康に重大な利点をもたらします.
- この集団のケアを最適化するために,授乳期医薬品の安全性データの不足に対処することが不可欠です.
- 先進的なモデリング技術は,授乳中のCKD治療の安全性を決定するのに役立ちます.
関連する概念動画
Pharmacokinetics in Pediatric Patients: Drug Excretion
284
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
284
Acute Kidney Injury IV: Diagnostic Studies and Prevention
354
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
354
Kidney Transplant III: Nursing Management
417
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
417
Renal Failure: Dose Adjustments
502
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
502
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.2K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.2K
Acute Kidney Injury VI: Nursing Management
518
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
518


